Subaiea, G.; Rizvi, S.M.D.; Yadav, H.K.S.; Al Hagbani, T.; Abdallah, M.H.; Khafagy, E.-S.; Gangadharappa, H.V.; Hussain, T.; Abu Lila, A.S.
Ganetespib with Methotrexate Acts Synergistically to Impede NF-κB/p65 Signaling in Human Lung Cancer A549 Cells. Pharmaceuticals 2023, 16, 230.
https://doi.org/10.3390/ph16020230
AMA Style
Subaiea G, Rizvi SMD, Yadav HKS, Al Hagbani T, Abdallah MH, Khafagy E-S, Gangadharappa HV, Hussain T, Abu Lila AS.
Ganetespib with Methotrexate Acts Synergistically to Impede NF-κB/p65 Signaling in Human Lung Cancer A549 Cells. Pharmaceuticals. 2023; 16(2):230.
https://doi.org/10.3390/ph16020230
Chicago/Turabian Style
Subaiea, Gehad, Syed Mohd Danish Rizvi, Hemant Kumar Singh Yadav, Turki Al Hagbani, Marwa Helmy Abdallah, El-Sayed Khafagy, Hosahalli Veerabhadrappa Gangadharappa, Talib Hussain, and Amr Selim Abu Lila.
2023. "Ganetespib with Methotrexate Acts Synergistically to Impede NF-κB/p65 Signaling in Human Lung Cancer A549 Cells" Pharmaceuticals 16, no. 2: 230.
https://doi.org/10.3390/ph16020230
APA Style
Subaiea, G., Rizvi, S. M. D., Yadav, H. K. S., Al Hagbani, T., Abdallah, M. H., Khafagy, E.-S., Gangadharappa, H. V., Hussain, T., & Abu Lila, A. S.
(2023). Ganetespib with Methotrexate Acts Synergistically to Impede NF-κB/p65 Signaling in Human Lung Cancer A549 Cells. Pharmaceuticals, 16(2), 230.
https://doi.org/10.3390/ph16020230